Analyzers
These analyzers are used for disease testing for heart disease, cancer, diabetes, infectious diseases and hormonal disorders related to lifestyle.
Analyzers
These analyzers are used for disease testing for heart disease, cancer, diabetes, infectious diseases and hormonal disorders related to lifestyle.


AFIAS COVID-19 Ab automated immunoassay in conjunction with AFIAS-1 analyzer
The AFIAS COVID-19 Ab (in conjunction with AFIAS-6 analyzer) is a fluorescence Immunoassay intended for the qualitative detection of IgG/IgM antibodies to SARS-CoV-2 in serum, plasma, venous whole blood or fingerstick capillary whole blood samples from individuals with current or prior COVID-19 infection. The AFIAS COVID-19 Ab is intended for use as an aid in identifying patients with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
AFIAS-6 is a multi-channel automated immunoassay analyzer which enables the user to simultaneously perform the same test on six different clinical samples or simultaneously perform six different AFIAS IVD tests. AFIAS-6 detect or measures the concentration of target analyte in a clinical sample loaded onto a self-contained test cartridge which is then inserted in one of the six test cartridge ports of the analyzer to automatically complete further steps to display the test result.
AFIAS-6 automated test process enables to carry out multiple simultaneous tests for six different samples. For some tests, such as TSH, CRP, PCT, and HbA1c, a quantitative test can be performed using a small sample (30uL) of whole blood from a finger or heel using an applicable C-tip (capillary tip).
For information to enhance your AFIAS-1 experience or if you'd like more information on our all in one cartridge release schedule contact us here.

The AFIAS-6 features
-
24 Tests per hour
-
6 Simultaneous Testing Channels
-
Fully Automatic
-
LIS Connectivity
-
Capillary Blood, Serum or Plasma
-
keyboard Adaptable
AFIAS-6

AFIAS COVID-19 Ab Test Cartridge
AFIAS COVID-19 Ab test cartridge is an unitized, self-contained, ready-to-use test device to be used in conjunction with AFIAS-1 or AFIAS-6 analyzer by simply loading the clinical sample onto the test cartridge thereby offering great convenience to the user. AFIAS-1 and AFIAS-6 analyzers qualitatively detects IgG/IgM antibodies to SARS-CoV-2 in serum, plasma, venous whole blood or fingerstick capillary whole blood samples to automatically display the result after 10 minutes. The AFIAS COVID-19 Ab test cartridge is marked with a barcode, which signifies the identity of the test cartridge after sample-loaded test cartridge is inserted in and scanned by the analyzer
Detection Buffer Well

Sample Well
Detection Zone
Loading Well

AFIAS-6 Technical Specifications for AFIAS COVID-19 Ab test
Throughput
Number of channels
Sample
Cartridge
Measuring principle
Calibration
Monitor/Keyboard
Connectivity
Power Input
Dimension / Weight
Instrument type
Temp. Range
10 min per test / Up to 24 tests per hour
Six Simultaneous Channels
Serum/plasma/venous whole blood (150µL to be added in the sample well of the test cartridge) Fingerstick capillary whole blood to be collected into the AFIAS C-tip (30 µL) directly from the patient
Ready to use “all in one cartridge”
Lateral flow sandwich detection immunofluorescence assay
Master calibration formula provided through lot-specific test ID Chip.
User-level calibration not required for AFIAS COVID-19 Ab test
7” LCD touch screen, built-in thermal printer, bluetooth keyboard (optional)LIS/HIS compatible, RS 232, USB port
100 ~ 240 V AC (50/60 Hz) / 1.8 A
420 mm (L) x 336 mm (W) x 293 mm (H) / 15.1kg
High throughput compact automated immunoassay analyzer
20 ~ 50 °C

AFIAS-6 Resources


AFIAS-6 - COVID-19 Test introduction
AFIAS-6 Test Introduction

AFIAS-6 - Installation Guide
AFIAS-6 Installation Guide

AFIAS-6 - System Check, Control & Calibration
AFIAS-6 System Check

AFIAS - C-Tip Technology
AFIAS-6 C-Tip Technology

AFIAS-6 - System Check, Control & Calibration
AFIAS-6 Washing Cartridge
Frequently Asked Questions
In the USA, this product has not been FDA cleared or approved; but has been authorized by FDA under an EUA;
·This product has been authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens; and,
·The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro
diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.
·For more information on EUAs please visit:
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergencyuse-authorization
·For the most up to date information on COVID-19, please visit: www.cdc.gov/COVID19
Having symptoms of weakness, dizziness, pale skin and cold hands and feet, Parents or other immediate family members have had a history of any blood disorder, If current diet is very low in iron and mineral content, Suffering from a long-term infection, They have suffered an excessive blood loss due to injury or surgical procedure, They are pregnant.



